| Title |
Longitudinal Study of CSF Biomarkers in Patients with Alzheimer's Disease
|
|---|---|
| Published in |
PLOS ONE, July 2009
|
| DOI | 10.1371/journal.pone.0006294 |
| Pubmed ID | |
| Authors |
Peder Buchhave, Kaj Blennow, Henrik Zetterberg, Erik Stomrud, Elisabet Londos, Niels Andreasen, Lennart Minthon, Oskar Hansson |
| Abstract |
The CSF biomarkers tau and Abeta42 can identify patients with AD, even during the preclinical stages. However, previous studies on longitudinal changes of tau and Abeta42 in individual patients with AD and elderly controls report somewhat inconsistent results. |
Mendeley readers
The data shown below were compiled from readership statistics for 80 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| France | 2 | 3% |
| Netherlands | 1 | 1% |
| Austria | 1 | 1% |
| United Kingdom | 1 | 1% |
| Belgium | 1 | 1% |
| Unknown | 74 | 93% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 19 | 24% |
| Student > Ph. D. Student | 18 | 23% |
| Student > Master | 9 | 11% |
| Other | 6 | 8% |
| Professor | 3 | 4% |
| Other | 12 | 15% |
| Unknown | 13 | 16% |
| Readers by discipline | Count | As % |
|---|---|---|
| Agricultural and Biological Sciences | 18 | 23% |
| Neuroscience | 15 | 19% |
| Medicine and Dentistry | 11 | 14% |
| Psychology | 5 | 6% |
| Biochemistry, Genetics and Molecular Biology | 2 | 3% |
| Other | 7 | 9% |
| Unknown | 22 | 28% |